myTomorrows provides a cloud‑based platform that aggregates clinical trial and expanded access data, using AI to pre‑screen patients and match them with suitable treatment options. The service connects patients, physicians, and trial sites through secure, compliant tools and dedicated patient navigators, while offering BioPharma companies targeted recruitment and real‑world data collection.
Funding
$10.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
2OFounders
Product
Problem
Patients with serious or rare diseases often struggle to find and access clinical trials or expanded access programs because relevant information is scattered across multiple registries, and navigating eligibility, referrals, and regulatory requirements is complex and time‑consuming.
Solution
myTomorrows offers a cloud‑based platform that aggregates trial and expanded access data from trusted registries and applies AI‑driven pre‑screening to match patients’ medical profiles with suitable options. The service connects patients, their physicians, and trial sites through a secure, GDPR‑compliant environment, and assigns multilingual patient navigators to guide users through referral, enrollment, and compassionate‑use processes. For healthcare professionals, the platform provides rapid search, eligibility checks, and direct communication tools with trial sites, all at no cost. BioPharma partners benefit from targeted patient recruitment, end‑to‑end expanded access program management, and real‑world data collection, all supported by ISO 27001, SOC 2, and GMP‑aligned quality systems.
Target Audience
Primary users are patients with serious or rare diseases and their caregivers, as well as treating physicians seeking timely trial or EAP options; BioPharma companies and CROs use the platform for patient recruitment, EAP management, and RWD generation.
Features
- Unified search engine that pulls real‑time data from multiple public trial registries covering over 200 countries
- AI‑powered eligibility pre‑screening that filters options based on a patient’s specific clinical profile
- Dedicated patient navigator assigned to each case, acting as a single point of contact for patients, families, and physicians
- Secure, ISO 27001‑certified platform with GDPR, HIPAA, and SOC 2 compliance for data handling and communications
- Integrated referral workflow enabling physicians to submit qualified patients directly to trial sites via a compliant messaging hub
- Full‑service expanded access program (EAP) support, including application preparation, logistics, and regulatory documentation
- Real‑World Data (RWD) collection tools for BioPharma to capture outcomes and safety information from treated patients